RECRO PHARMA INC's ticker is and the CUSIP is 75629F909. A total of 3 filers reported holding RECRO PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | +100.0% | 12,200 | -6.9% | 0.00% | – |
| Q2 2022 | $10,000 | -93.4% | 13,100 | -84.5% | 0.00% | – |
| Q1 2022 | $152,000 | -3.8% | 84,400 | -8.8% | 0.00% | – |
| Q4 2021 | $158,000 | -36.8% | 92,500 | -23.7% | 0.00% | – |
| Q3 2021 | $250,000 | +48.8% | 121,300 | +66.9% | 0.00% | – |
| Q2 2021 | $168,000 | +211.1% | 72,700 | +276.7% | 0.00% | – |
| Q1 2021 | $54,000 | +170.0% | 19,300 | +175.7% | 0.00% | – |
| Q4 2020 | $20,000 | +42.9% | 7,000 | +1.4% | 0.00% | – |
| Q3 2020 | $14,000 | -30.0% | 6,900 | +56.8% | 0.00% | – |
| Q2 2020 | $20,000 | 0.0% | 4,400 | +83.3% | 0.00% | – |
| Q1 2020 | $20,000 | -94.0% | 2,400 | -86.9% | 0.00% | -100.0% |
| Q4 2019 | $335,000 | +95.9% | 18,300 | +18.8% | 0.00% | +100.0% |
| Q3 2019 | $171,000 | -76.3% | 15,400 | -78.3% | 0.00% | -85.7% |
| Q2 2019 | $722,000 | +243.8% | 71,000 | +98.3% | 0.01% | +250.0% |
| Q1 2019 | $210,000 | – | 35,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 121,300 | $250,000 | 0.00% |
| SIMPLEX TRADING, LLC | 11,400 | $25,000 | 0.00% |